<DOC>
	<DOC>NCT02316730</DOC>
	<brief_summary>24 healthy male volunteers are to be assigned to take orally Sanchi-Tongshu Capsule (Enteric coated pellets) and Sanchi-Tongshu Capsule in fasting condition according to a randomized, crossover, self-control method, with ginsenoside Rg1, ginsenoside Re and notoginsenoside R1 as detection indicators. Establish the "blood drug concentration-time " curve, compare the bioequivalence of the main effective ingredients of the two preparations during the absorption process in human.</brief_summary>
	<brief_title>A Bioequivalence Study of Sanchi-Tongshu Capsule (Enteric Coated Pellets)</brief_title>
	<detailed_description />
	<criteria>The healthy male volunteers aged 1840 years old; The body mass index is within 1924, and the body weight is not less than 50kg( body mass index=body weight (kg)/height (M)2); All the examination indicators such as heart, liver, kidney, blood and so on are within normal range; The subjects should be without the addiction to smoking or alcohol, without drug abuse history and agree not to drink beverages containing caffeine during the trial; The subjects fully understand the objective, method and content of the trial, as well as the test preparation and reference preparation, and are willing to sign informed consent. The subjects that are found to have any significant clinical diseases by direct questioning and comprehensive physical examination and laboratory examination before study; Allergic constitution, such as the patients with allergy history to two or more food and drugs; or those known to be allergic to the ingredient of the drug. The individuals with low possibility of enrollment (such as physically weak and so on) according to investigator's judgement; The patients that have any reasons considered by the investigator to prevent the subjects from finishing the study.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>